AzTrials
AzTrials

Uterine AnteflexionFLEXIMIX 2NCT07084766

The Variation in Uterine Flexion Angle Before and After Voiding in Parous Women.

A study testing ultrasonography, pelvic in people with Uterine Anteflexion and Parous Women, run by University Hospital, Brest at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intrauterine devices (IUDs) account for approximately 25% of contraceptive methods used in France. However, their insertion can be painful for patients and challenging for practitioners, particularly due to the passage through the cervix and the uterine flexion angle. Read more about this study

Who is it for?
Ages 18 to 65 years, women only
Conditions the study is for
Uterine Anteflexion, Parous Women
What is being tested?
ultrasonography, pelvic
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteFrance
Study dates
25 Sep 2025to 30 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult women
  • Parous
  • Experiencing the need to urinate
  • Affiliated with a social security scheme or equivalent

Who cannot join

  • Pregnant women
  • Desire for pregnancy with ongoing conception process
  • Age > 65 years
  • History of hysterectomy
  • History of conization
  • Childbirth < 6 months
  • Irrepressible need to urinate
  • Inability or refusal to participate in the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU Brest

    Brest, Finistere, 29200

Other trials in France

About this study

Intrauterine devices (IUDs) account for approximately 25% of contraceptive methods used in France. However, their insertion can be painful for patients and challenging for practitioners, particularly due to the passage through the cervix and the uterine flexion angle. An interventional study conducted by Cameron in 2013 examined the impact of bladder filling on the ease of IUD insertion. The results did not show a significant benefit, suggesting that a full bladder does not necessarily improve the procedure. An ongoing study, FLEXIMIX, led by the coordinator, explores the variation in the uterine flexion angle based on bladder filling in 250 nulliparous women. Preliminary results indicate a strong influence of bladder filling on the flexion angle. Additionally, the Valsalva maneuver, which involves increasing intra-abdominal pressure by forceful exhalation against a closed glottis, has been shown in two recent studies to facilitate gynecological interventions by improving cervical passage, thereby reducing the need for invasive instruments such as the tenaculum.What happens in parous women and during the Valsalva maneuver remains to be explored.

Being tested
ultrasonography, pelvic
Keywords
uterine anteflexion, nulliparous women, full bladder, angle of anteflexion or retroflexion of the uterus, ultrasound measurements

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasonography, pelvicProcedure or surgery

    Ultrasound measurements will be taken before and after bladder emptying. The axes of the uterine body, cervix and vagina will be marked out by tracing the 3 corresponding lines on the image.

Study groups in NCT07084766
Study groupRoleWhat they receive
Transabdominal ultrasonographyOtherUltrasound measurements before and after bladder emptying
Receives: Procedure: ultrasonography, pelvic

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference between the mean angles of uterine anteflexion and retroflexion with a full and empty bladder in parous women

    To determine the difference between the mean angles of uterine anteflexion and retroflexion with a full and empty bladder in parous women

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jul 2025
  2. Study start25 Sep 2025
  3. Primary completion30 Oct 2025
  4. Study completion30 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07084766
Sponsor's protocol ID
29BRC25.0036
Other IDs
ID RCB
Acronym
FLEXIMIX 2
Status last verified
Dec 2025
First submitted
17 Jul 2025
Last updated
19 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing ultrasonography, pelvic in people with Uterine Anteflexion and Parous Women, run by University Hospital, Brest at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference between the mean angles of uterine anteflexion and retroflexion with a full and empty bladder in parous women (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in